Comparative Evaluation of Three In Vitro Techniques in the Interaction of Ampicillin and Ciprofloxacin against Staphylococcus aureus and Escherichia coli by Nworu, C S & Esimone, C O
Nworu & Esimone
                       
Trop J Pharm Res, December 2006; 5 (2) 605
Tropical Journal of Pharmaceutical Research, December 2006; 5 (2): 605-611 
© Pharmacotherapy Group,  
Faculty of Pharmacy, University of Benin,  
Benin City, Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
Research Article 
 
Comparative Evaluation of Three In Vitro Techniques 
in the Interaction of Ampicillin and Ciprofloxacin 
against Staphylococcus aureus and Escherichia coli. 
 
 
*CS Nworu1 and CO Esimone2   
1 Department of Pharmacology and Toxicology, 








Purpose: The study was designed to evaluate the consistency of interpretation of results of interaction 
between ampicillin and ciprofloxacin against S. aureus and E. coli using three in vitro techniques. 
Methods: The interaction between ampicillin and ciprofloxacin was studied using three in vitro methods- 
Checkerboard technique, Overlay Inoculum Susceptibility Disc technique (OLISD) and the Decimal 
Assay for Additivity technique (DAA).  
Results: In the Checkerboard technique, fractional inhibitory concentration (FIC) indices show that the 
ampicillin/ciprofloxacin combination is synergistic against the test organisms. In the DAA approach, a 
target IZD of 15 mm yielded Biological Equivalent Factors (BEF) of 1.35 µg (amp/Staph), 6.74 µg 
(cipro/Staph), 9.62 µg (ampicillin/E. coli), and 5.45 µg (cipro/E. coli). Statistical analyses show that all 
decimal combinations of ampicillin and ciprofloxacin were additive (p< 0.05). The overlay inoculum 
susceptibility disc method shows inhibition zone diameter increments ranging between 36 ± 8.00 % to 
69.2 ± 23.08 % for S. aureus and 28.12 ± 3.13 % to 50 ± 12.50 % for E. coli. These increments are 
consistent with reported criteria for synergism in the OLISD method. 
Conclusion: The study suggests a possible clinical use for the combination of ampicillin and 
ciprofloxacin against infections caused by these organisms. Equally, the apparent disagreement 
between DAA and the other two methods raises questions as to the consistency of inferences drawn on 
interaction studies when different techniques are used. 
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The simultaneous use of two or more 
antimicrobial agents has certain rationale and is 
recommended in specifically defined situations1,2 
Several reasons have been advanced to justify 
the use of combination of two or more antibiotic 
treatment2,3 For many years now, combination of 
two or more antibiotics has been recognized as 
an important method for, at least, delaying the 
emergence of bacterial resistance4. Besides, 
antibiotic combinations may also produce 
desirable synergistic effects in the treatment of 
bacterial infections5. 
 
However, the selection of an appropriate 
combination requires an understanding of the 
potential for interaction between the 
antimicrobial agents. Accordingly, methods have 
been developed to quantify the effect of 
antimicrobial combinations on bacterial growth in 
vitro. Two very distinct traditional methods of 
testing in vitro antibiotic interaction are the 
checkerboard technique and the time killing 
curve method6. Operational limitations inherent 
in the usual methods of evaluating bacterial 
susceptibility to antibiotic combinations make the 
need for an improved method imperative. 
Chinwuba et al7 developed with a technique- 
Overlay Inoculum Susceptibility Disc (OLISD) 
method. This is essentially a modification of the 
disc agar diffusion method. Sanders et al8 
observed that there is no quantitative dose-
effect relationship and no precisely defined end-
points of additivity in the traditional methods. 
They went ahead to describe a new in vitro test 
for antimicrobial agents used in combination8. 
This new method, the Decimal Assay for 
Additivity (DAA) was based on disc diffusion 
assay and was designed to have a precisely 
defined end point for additivity so that 
interactions greater or less than additivity could 
be respectively defined as synergism or 
antagonism. 
 
Ampicillin is a commonly used broad-spectrum 
aminopenicillin with known activity against E. 
coli and Staph. aureus. Its clinical usefulness is 
limited by its susceptibility to β-lactamase 
hydrolysis produced by these organisms. 
Ciprofloxacin is a broad–spectrum 
fluoroquinolone and possess good activity 
against E. coli and Staph. aureus. Recently, 
there are reports of resistance to this, hitherto, 
effective group of antibiotics. Chromosomal 
mutation in subunit A of DNA-gyrase has been 
identified as a possible cause of bacterial 
resistance9. Resistance to quinolones by efflux 
mechanisms has equally been described in 
Staph aureus10. 
 
In this study, the interaction between ampicillin 
and ciprofloxacin is investigated using three in 
vitro methods-the Checkerboard titration 
technique, the Decimal Assay for Additivity, and 
the Overlay Inoculum Susceptibility Disc 
(OLISD) method. The result of the study could 
provide rational basis for clinical use of these 
two antibiotics against infections caused by 
these organisms. The study will also provide an 
insight into the degree of consistency of 
inferences drawn from results of in vitro 
antibiotic interactions using different methods of 
evaluation. 
 
MATERIALS AND METHODS 
Culture media 
The media employed for the study are 
McConkey agar (Oxoid), agar-agar (Oxoid) and 
nutrient broth (Merck) 
 
Test microorganisms 
The organisms used were type strains of 
Staphylococcus aureus (ATCC 12600) and E. 
coli (ATCC 11775) obtained from the 
Bioresources Development and Conservation 
Programme (BDCP) Centre, Nsukka, Enugu 
State, Nigeria. 
 
Drugs and Disc 
Pure samples of Ampicillin powder was kindly 
supplied by Doyin Pharmaceutical Company, 
Limited, Lagos, Nigeria. Ciprofloxacin 
hydrochloride was extracted from the tablet 
dosage form (Ciproflox)®, Orange drugs limited, 
Nigeria. These drugs were employed to prepare 
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the antibiotic disc using whatmann No 1 filter 
paper in accordance with the NCCL standards11. 
 
Maintenance and standardization of test 
organisms 
The organisms were maintained by weekly sub-
culturing on McConkey agar-slants (E. coli) and 
nutrient agar slant (S. aureus) stored at 4 ˚C 
after previous 24 h incubation at 37 ˚C. Before 
each experiment, the microorganisms were 
activated by successive sub-culturing and 
incubation. Twenty-four hour old culture of test 
organism was always used. Standardization of 
test micro organism was according to previously 
reported method7,12  
 
Sensitivity of test micro-organisms 
The sensitivity of test microorganisms to 
ampicillin and ciprofloxacin hydrochloride was 
evaluated by determining the minimum inhibitory 
concentration (MIC) of the antibiotics using the 
two-fold broth dilution technique previously 
described11,12. 
 
Evaluation of Combined Activity of 
ciprofloxacin and ampicillin using the            
Checkerboard-technique 
Stock solutions of ampicillin (400  µg/ml) and 
ciprofloxacin (5 µg/ml) prepared in double-
strength nutrient broth and autoclaved at 121˚C 
for 15 minutes were employed. Thereafter, 
varying proportions of ampicillin (A) and 
ciprofloxacin (C) were prepared according to the 
continuous variation checkerboard method 
previously described 11. 
 Each proportion of antibiotic combination was 
serially diluted (2 –fold), inoculated with 0.1ml of 
106 cfu/ml culture of the test microorganism and 
then incubated for 24 h at 37˚C. Interaction was 
assessed algebraically by determining the 
fractional inhibitory concentration (FIC) indices 
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Evaluation of combined activity of 
ciprofloxacin and ampicillin using  Decimal 
Assay for Additivity (DAA) 
 This method was first described by Sanders et 
al8. Antibiotic discs of graded drug 
concentrations were prepared in compliance 
with the NCCL standards11.  
Standard dose effect-curves. A standard dose-
effect relationship was obtained for each 
antibiotic against each test organism using discs 
of graded drug concentrations in a range 
capable of yielding linear relationship for log 
dose versus IZD plot. 
 Biological Equivalence Factor (BEF). For each 
micro-organism, a common target zone of 
inhibition was selected at the mid-range of 
standard dose-effect curve of each antibiotic. A 
suitable IZD of 15mm was chosen as target. 
Using the linear regression equations of the 
standard plot, the quantities of the various drug 
required to produce the target inhibition zone 
were calculated. This quantity for each antibiotic 
represents what has been described as 
biological equivalence factor (BEF)8. 
Interaction by DAA technique. Once the BEFs of 
the antibiotics against each organism have been 
determined, series of eleven decimal mixtures of 
the 10 parts BEF of (A) +10 parts BEF of (C) 
were prepared. These solutions were used to 
prepare the disc on sterilized Whatman No. 1 
fitter paper discs of diameter 6mm. Thereafter, 
the discs were aseptically placed on nutrient 
agar plates previously seeded with a 
standardized inoculums of the test organism and 
the plates incubated at 37˚C for 24 h. The 
procedures were replicated and mean values of 
IZDs recorded after incubation. The nature of 
interaction was judged statistically according to 
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the recommendation of Sanders et al8. The level 
of significance was decided based on a 95% 
confidence interval set up for a target zone of 
15mm. 
 
Evaluation of combined activity of 
ciprofloxacin and ampicillin by OLISD 
technique  
The method was first reported by Chinwuba et 
al7. The procedure is basically a modification of 
the disc agar diffusion method. A solution of 
ampicillin was prepared in molten nutrient agar 
to yield about 50% of the MIC of the ampicillin 
against each test microorganism. Then 20 ml of 
the antibiotic seeded agar was poured in the 
Petri-dish to form the base agar-layer and 5 ml 
of molten antibiotic free agar containing 106  
cfu/ml was applied as a thin overlay inoculum-
agar layer and allowed to solidify. The 
ciprofloxacin antibiotic discs of varying drug 
concentrations were placed on the solidified 
surface and the plates incubated at 370C for 24 
h.. The petri dishes so treated were taken as the 
test plates. The control plates were similarly 
prepared without any antibiotic on the base 
agar-layer. The mean percentage increases in 
IZD’s of the test over the control groups were 
determined. The interaction results were then 
determined according to recommended criteria 
7.  
 
RESULTS AND DISCUSSION  
E. coli was more sensitive than Staph. aureus  
to ampicillin (MICs of 25 ± 1.20 µg/ml and 125 ± 
2.50 µg/ml, respectively) while Staph. aureus 
was more sensitive than E. coli to ciprofloxacin 
(MICs of 0.3 ± 0.15 µg/ml and 0.625 ± 0.25 
µg/ml, respectively) as indicated by their 
respective MIC values. 
  In the Checkerboard technique, the 
interaction between pair combinations of 
ampicillin and ciprofloxacin against Staph 
aureus and E. coli were predominantly 
synergistic, although there were few variations 
(Tables 1). FICindex values < 1were considered 
as synergy and the degree of synergy increases 
as the value tends towards zero. FIC-index 
value of one show additivity, values greater than 
one, but less than two represent indifference 
while values greater than two show 
antagonism7,12. Seven out of nine pair  
 
Table 1. combined activity of ampicillin and ciprofloxacin against S. aureus

































































































































A = Ampicillin 
C = Ciprofloxacin  
FIC = Fractional Inhibitory Concentration  
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Table 2:  Interactions between ampicillin and ciprofloxacin against Staph.  aureus by DAA technique 
 
 Drug  Diameter of target                  BEF           Practical mean 95% CIa                  Type of inference  
 zone inhibition (mm)   IZD (mm)  
10(A)+0(C) 15  1.353µg  15.0  13.04-16.96 --- 
0(A)+10(C) 15  6.74µg               15.25  14.14-16.01 --- 
9(A)+1(C) -   -  17.25  16.75-17.74 Additive (P>0.05)b 
8(A)+2(C) -   -  15.5  14.52-16.48 Additive (P>0.05) 
7(A)+3(C) -   -  16.5  15.52-17.48 Additive (P>0.05) 
6(A)+4(C) -   -  16.5  15.25-17.48 Additive (P>0.05) 
5(A)+5(C) -   -  16.25  15.25-17.48 Additive (P>0.05) 
4(A)+6(C) -   -  15.5  15.76-16.74 Additive (P>0.05) 
3(A)+7(C) -   -  14.5  14.52-16.48 Additive (P>0.05) 
2(A)+8(C) -   -  14.5  13.52-15.48 Additive (P>0.05) 
1(A)+9(C) -   -  14.5  13.52-15.48 Additive (P>0.05) 





Table 3: Interactions between ampicillin and ciprofloxacin  against E. coli by DAA technique 
 
Drug    Diameter of target  BEF  Practical mean  95% CIa   Type of inference  
    zone inhibition (mm)   IZD (mm)  
10(A)+0(C) 15  9.62  16.0  14.04-15.48          --- 
0(A)+10(C) 15  5.45  14.5  13.52-15.48          --- 
9(A)+1(C) -   -  17.5  14.56-20.44 Additive (P>0.05)b 
8(A)+2(C) -   -  16.5  13.56-19.44 Additive (P>0.05) 
7(A)+3(C) -   -  18.5  17.52-19.48 Additive (P>0.05) 
6(A)+4(C) -   -  19.0  17.04-20.96 Additive (P>0.05) 
5(A)+5(C) -   -  17.5  14.56-20.44 Additive (P>0.05) 
4(A)+6(C) -   -  16.0  14.04-17.96 Additive (P>0.05) 
3(A)+7(C) -   -  13.5  10.56-16.44 Additive (P>0.05) 
2(A)+8(C) -   -  12.5  11.52-13.48 Additive (P>0.05) 
1(A)+9(C) -   -  18.0  14.08-21.92 Additive (P>0.05) 
aCI, Confidence interval 95% 




Table 4. Interaction between ampicillin and ciprofloxacin against S. aureus and   
E. coli by OLISD-technique. 
Mean inhibition zone 
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produced synergistic effect against Staph 
aureus. In E. coli, the antibiotic combination 
resulted in the MIC of ampicillin decreasing from 
125 µg/ml to a very low value of 1.5 µg/ml in 1 
(A) + 9(c) mixture) and that of ciprofloxacin 
decreasing from 0.625 µg/ml to 0.0313 µg/ml. 
Only two decimal mixtures [9 (A) + 1 (C) and 1 
(A) + 9 (C)] deviated from synergism and were, 
respectively, indifference or additive.          
  
The Biologic Equivalent Factors [calculated on a 
target IZD of 15 mm from regression equations 
of plots of IZD versus log (disc drug 
concentrations)] are 1.353 µg (ampicillin/Staph. 
aureus), 11.41 µg (ampicillin/E. coli), 8.994 µg 
(ciprofloxacin/S. aureus), 5.45 µg (ciprofloxacin/ 
E. coli). In the interaction study by DAA, all the 
decimal combinations produced an additive 
interaction against both organisms (Table 2 and 
3). The inhibition zone diameters produced by 
the pair combinations were similar to that 
produced by each of the antibiotics acting alone. 
At 95 % confidence interval, there is no 
statistically significant difference between the 
IZD’s of pair combinations and that of ampicillin 
and ciprofloxacin alone5. Although, additivity is a 
positive interaction, the inference from this 
method is not in agreement with that of the 
Checkerboard technique.  
 In the OLISD technique (Table 4), all the 
IZD increments were above 19 % and is 
interpreted as synergism7. This agrees with the 
inference obtained in the Checkerboard method 
and differs with that of the DAA approach. 
Ampicillin and ciprofloxacin are both bactericidal, 
but they act through different mechanisms and 
at different sites on bacteria cells. Ampicillin 
inhibit the formation and integrity of the bacteria 
cell wall while ciprofloxacin inhibit DNA –
gyrase4,9. Jawtez et al13 observed that 
concomitant use of two bactericidal antibiotics is 
likely to produce synergistic effect. The results of 
this study have demonstrated either synergism 
or additive interaction against the test 
organisms. Although, these inferences are all 
potentiation of activity, the apparent 
disagreement between the DAA approach and 
the other two methods call to question the issue 
of uniformity and standardization of techniques 
to avoid conflicting results in interaction studies.  
It is hoped that these approaches, if well 
standardized and adopted, will not only provide 
useful alternatives to pre-existing time-kill and 
checkerboard titration method, but will also 
circumvent problems and methodological 
limitations inherent in their use.8 
The possibility of a combination of these two 
antibiotics limiting the development and spread 




Based on results obtained, ampicillin interacts 
with ciprofloxacin to produce a synergistic 
antibacterial activity against strains of Staph. 
aureus and Escherichia coli in the majority of the 
cases. Actual clinical experiences are needed to 
conclude on possible clinical benefits of using 
these two antibiotics in combination. The 
apparent disagreement between DAA approach 
and the other two methods needs further 
investigation with a view to standardizing 
techniques to avoid variation of inferences and 
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